Central role of defective apoptosis in autoimmunity

Journal of Molecular Endocrinology

Volumn 31, Issue 3, 2003, Pages 373-399

  Kuhtreiber W M ^a   Hayashi, T ^a   Dale, E A ^a   Faustman, D L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; ALPHA GALACTOSYLCERAMIDE; ANDROGEN; AZATHIOPRINE; BACLOFEN; BCG VACCINE; BEE VENOM; CALCITRIOL; CASEIN HYDROLYSATE; CHOLERA TOXIN B SUBUNIT; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DAPSONE; DIAZOXIDE; DIMETHYL SULFOXIDE; FAS ANTIGEN; FAS LIGAND; FREUND ADJUVANT; GLUCOSE; HEAT SHOCK PROTEIN 65; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; LYMPHOTOXIN; PROTEASOME; PROTEIN SUBUNIT; RECOMBINANT INTERLEUKIN 4; ROQUINIMEX; TACROLIMUS; UNINDEXED DRUG;

ANIMAL MODEL; APOPTOSIS; AUTOIMMUNE DISEASE; CELL MATURATION; CELL SELECTION; DIABETES MELLITUS; DRUG EFFICACY; GENE MUTATION; HUMAN; IMMUNE SYSTEM; LYMPHATIC SYSTEM; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TRANSCRIPTION INITIATION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; AUTOIMMUNITY; FAS LIGAND PROTEIN; HUMANS; LUPUS; LYMPHOCYTES; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED NOD; MUTATION; NF-KAPPA B; PROTEASOME ENDOPEPTIDASE COMPLEX; T-LYMPHOCYTES;

EID: 0346728631     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0310373     Document Type: Review

References (298)

1. Akiyama KY, Yokota KY, Kagawa S, Shimbara N, Tamura T, Akioka H, Nothwang HG, Noda C, Tanaka K & Ichihara A 1994 cDNA cloning and interferon γ down-regulation of proteasomal subunits x and y. Science 265 1231-1234.
2. + T cells in Tap-1 mutant mice. PNAS 91 6525-6528.
3. Allen RD, Marshall JD, Roths JB & Sidman CL 1990 Differences defined by bone marrow transplantation suggest that lpr and gld are mutations of genes encoding an interacting pair of molecules. Journal of Experimental Medicine 172 1367-1375.
4. Amrani A, Verdaguer J, Anderson B, Utsugi T, Bou S & Santamaria P 1999 Perforin-independent β-cell destruction by diabetogenic CD8(+) T lymphocytes in transgenic nonobese diabetic mice. Journal of Clinical Investigation 103 1201-1209.
5. Andersson A, Forsgren S, Soderstrom A & Holmberg D 1991 Monoclonal, natural antibodies prevent development of diabetes in the non-obese diabetic (NOD) mouse. Journal of Autoimmunity 4 733-742.
6. Arreaza GA, Cameron MJ, Jaramillo A, Gill BM, Hardy D, Laupland KB, Rapoport MJ, Zucker P, Chakrabarti S, Chensue SW, Qin HY, Singh B & Delovitch TL 1997 Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism. Journal of Clinical Investigation 100 2243-2253.
7. Atkinson MA & Leiter EH 1999 The NOD mouse model of type I diabetes: as good as it gets? Nature Medicine 5 601-604.
8. Atkinson MA, MacLaren NK & Luchetta R 1990 Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 39 933-937.
9. Baeder WL, Sredy J, Sehgal SN, Chang JY & Adams LM 1992 Rapamycin prevents the onset of insulin-dependent diabetes mellitus (IDDM) in NOD mice. Clinical and Experimental Immunology 89 174-178.
10. Baeuerle PA & Baltimore D 1996 NF-κB: ten years after. Cell 87 13-20.
11. Balasa B, Boehm BO, Fortnagel A, Karges W, Van Gunst K, Jung N, Camacho SA, Webb SR & Sarvetnick N 2001 Vaccination with glutamic acid decarboxylase plasmid DNA protects mice from spontaneous autoimmune diabetes and b7/CD28 costimulation circumvents that protection. Clinical Immunology 99 241-252.
12. Baldwin AS 1996 The NF-κB and IκB proteins: new discoveries and insights. Annual Review of Immunology 12 141-179.
13. Beales PE & Pozzilli P 2002 Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type I diabetes. Diabetes/Metabolism Research and Review 18 114-117.
14. Beales PE, Williams A, Krug J, Signore A, Chianelli M, Andreani D & Pozzilli P 1992 Effect of tenidap, a novel anti-inflammatory compound on islet lymphocyte infiltration and diabetes incidence in the non obese diabetic (NOD) mouse. Diabetes and Metabolism 18 48-53.
15. Beales PE, Williams AJ, Signore A, Procaccini E, Xu S & Pozzilli P 1993 The effect of a heparin analogue, ITF-5005, on diabetes incidence and insulitis in the non-obese diabetic mouse. Diabetes Research and Clinical Practice 21 5-9.
16. Beales PE, Williams AJ, Albertini MC & Pozzilli P 1994 Vitamin E delays diabetes onset in the non-obese diabetic mouse. Hormone and Metabolic Research 26 450-452.
17. Beales PE, Hawa M, Williams AJ, Albertini MC, Giorgini A & Pozzilli P 1995 Baclofen, a γ-aminobutyric acid-B receptor agonist, delays diabetes onset in the non-obese diabetic mouse. Acta Diabetologia 32 53-56.
18. Beales PE, Liddi R, Giorgini AE, Signore A, Procaccini E, Batchelor K & Pozzilli P 1998 Troglitazone prevents insulin dependent diabetes in the non-obese diabetic mouse. European Journal of Pharmacology 357 221-225.
19. Becker KG, Simon RM, Bailey-Wilson JE, Freidlin B, Biddison WE, McFarland HF & Trent JM 1998 Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. PNAS 95 9979-9984.
20. Beg AA & Baltimore D 1996 An essential role lor NF-κB in preventing TNF-α-induced cell death. Science 274 782-784.
21. Beg AA, Sha WC, Bronson RT, Ghosh S & Baltimore D 1995 Embryonic lethality and liver degeneration in mice lacking the Re1A component of NF-κB. Nature 376 167-170.
22. Belich MP, Glynne RJ, Senger G, Sheer D & Trowsdale J 1994 Proteasome components with reciprocal expression to that of the MHC-encoded LMP proteins. Current Biology 4 769-776.
23. Belich MP, Salmeron A, Johnston LH & Ley SC 1999 Tpl-2 kinase regulates the proteolysis of the NF-κB-inhibitory protein NF-κBI p105. Nature 397 363-368.
24. Benhamou PY, Mullen Y, Clare-Salzler M, Sangkharat A, Benhamou C, Shevlin L & Go VL 1995 Essential fatty acid deficiency prevents autoimmune diabetes in nonobese diabetic mice through a positive impact on antigen-presenting cells and TH2 lymphocytes. Pancreas 11 26-37.
25. Bergerot I, Ploix C, Petersen J, Moulin V, Rask C, Fabien N, Lindblad M, Mayer A, Czerkinsky C, Holmgren J & Thivolet C 1997 A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. PNAS 94 4610-4614.
26. Bock T, Kjaer TW, Jorgensen M, Josefsen K, Rygaard J & Buschard K 1991 Reduction of diabetes incidence in NOD mice by neonatal glucose treatment. Acta Pathologica, Microbiologica et Immunologica Scandinavica 99 989-992.
27. Bohnline E, Lowenthal JW, Siekevitz M, Franza BR & Greene WC 1988 The same inducible nuclear proteins regulate mitogen activation of both the interleukin-2 receptor-α gene and type I HIV. Cell 53 827-836.
28. Bot A, Smith D, Bot S, Hughes A, Wolfe T, Wang L, Woods C & von Herrath M 2001 Plasmid vaccination with insulin B chain prevents autoimmune diabetes in nonobese diabetic mice. Journal of Immunology 167 2950-2955.
29. Bras A & Aguas AP 1996 Diabetes-prone NOD mice are resistant to mycobacterium avium and the infection prevents autoimmune disease. Immunology 89 20-25.
30. Brod SA, Malone M, Darcan S, Papolla M & Nelson L 1998 Ingested interferon α suppresses type I diabetes in non-obese diabetic mice. Diabetologia 41 1227-1232.
31. Burkly L, Hession C, Ogata L, Reilly C, Marconi LA, Olson D, Tizard R, Cate R & Lo D 1995 Expression of RELB is required for the development of thymic medulla and dendritic cells. Nature 373 531-536.
32. Burkly LC, Jakubowski A & Hattori M 1994 Protection against adoptive transfer of autoimmune diabetes mediated through very late antigen-4 integrin. Diabetes 43 529-534.
33. Buschard K, Hanspers K, Fredman P & Reich EP 2001 Treatment with sulfatide or its precursor, galactosylceramide, prevents diabetes in NOD mice. Autoimmunity 34 9-17.
34. Bushdid PB, Brantley DM, Yull FE, Blaeuer GL, Hoffman LH, Niswander L & Kerr LD 1998 Inhibition of NF-κB activity results in disruption of the apical ectodermal ridge and aberrant limb morphogenesis. Nature 392 615-618.
35. Caamano JH, Rizzo CA, Durham SK, Barton DS, Raventos-Suare C, Snapper CM & Bravo R 1998 Nuclear factor (NF)-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. Journal of Experimental Medicine 187 185-196.
36. Calafiore R, Basta G, Falorni A, Pietropaolo M, Picchio ML, Calcinaro F & Brunetti P 1993 Preventive effects of azathioprine (AZA) on the onset of diabetes mellitus in NOD mice. Journal of Endocrinological Investigation 16 869-873.
37. Calcinaro F, Gambelunghe G & Lafferty KJ 1997 Protection from autoimmune diabetes by adjuvant therapy in the non-obese diabetic mouse: the role of interleukin-4 and interleukin-10. Immunology and Cell Biology 75 467-471.
38. Cameron MJ, Arreaza GA & Delovitch TL 1997 Cytokine- and costimulation-mediated therapy of IDDM. Critical Reviews in Immunology 17 537-544.
39. Campbell IL, Oxbrow L & Harrison LC 1991 Reduction in insulitis following administration of IFN-γ and TNF-α in the NOD mouse. Journal of Autoimmunity 4 249-262.
40. Casteels K, Waer M, Laureys J, Valekx D, Depovere J, Bouillon R & Mathieu C 1998 Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine. Transplantation 65 1225-1232.
41. Cetkovic-Cvrlje M, Gerling IC, Muir A, Atkinson MA, Elliot JF & Leiter EH 1997 Retardation or acceleration of diabetes in NOD/lt mice mediated by intrathymic administration of candidate β-cell antigens. Diabetes 46 1975-1982.
42. Chang Y & Prud-homme GJ 1999 Intramuscular administration of expression plasmids encoding interferon-γ receptor/IGG1 or IL-4/IGG1 chimeric proteins protects front autoimmunity. Journal of Gene Medicine 1 415-423.
43. Charlton B, Taylor-Edwards C, Tisch R & Fathmam CG 1994 Prevention of diabetes and insulitis by neonatal intrathymic islet administration in NOD mice. Journal of Autoimmunity 7 549-560.
44. Chatenoud L, Thervet E, Primo J & Bach JF 1994 Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. PNAS 91 123-127.
45. Chaturvedi P, Agrawal B, Zechel M, Lee-Chan E & Singh B 2000 A self MHC class II β-chain peptide prevents diabetes in nonobese diabetic mice. Journal of Immunology 164 6610-6620.
46. Chervonsky AV, Wang Y, Wong FS, Visintin I, Flavell RA, Janeway CA Jr, & Matis LA 1997 The role of Fas in autoimmune diabetes. Cell 89 17-24.
47. Clare-Salzler MJ, Brooks J, Chai A, Van Herle K & Anderson C 1992 Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer. Journal of Clinical Investigation 90 741-748.
48. Coleman DL, Kuzava JE & Leiter EH 1990 Effect of diet on incidence of diabetes in nonobese diabetic mice. Diabetes 39 432-436.
49. Conti A & Maestroni GJ 1996 Role of the pineal gland and melatonin in the development of autoimmune diabetes in non-obese diabetic mice. Journal of Pineal Research 20 164-172.
50. Cooke A, Tonks P, Joues FM, O'Shea H, Hutchings P, Fulford AJ & Dunne DW 1999 Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunology 21 169-176.
51. Coux O & Goldberg AL 1998 Enzymes catalyzing ubiquitimation and proteolytic processing of the P105 precursor of nuclear factor κB1. Journal of Biological Chemistry 273 8820-8828.
52. Coux O, Tanaka K & Goldberg AL 1996 Structure and functions of the 20S and 26S proteasomes. Annual Review of Biochemistry 65 801-817.
53. Crisaa L, Mordes.JP & Rossini AA 1992 Autoimmune diabetes mellitus in the BB rat. Diabetes/Metabolism Reviews 8 9-37.
54. Cross SL, Halden NF, Lenardo M & Leonard WJ 1989 Functionally distinct NF-κB binding sites in the immunoglobulin κ and IL-2 receptor α chain genes. Science 244 466-468.
55. Dahlquist G & Kallen B 1997 Early neonatal events and the disease incidence in nonobese diabetic mice. Pediatric Research 42 489-491.
56. Daniel D & Wegmann DR 1996 Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). PNAS 93 956-960.
57. Dardenne M, Lepault F, Bendelac A & Bach JF 1989 Acceleration of the onset of diabetes in NOD mice by thymectomy at weaning. European Journal of Immunology 19 889-895.
58. Delovitch TL & Singh B 1997 The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the nod (published erratum in Immunity 1998 8 531). Immunity 7 727-738.
59. Desai-Mehta A, Lu L, Ramsey-Goldman R & Datta SK 1996 Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. Journal of Clinical Investigation 97 2063-2073.
60. Drappa J, Vaishnaw AK, Sullivan KE, Chu JL & Elkon KB 1996 Fas gene mutation in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity (see comments). New England Journal of Medicine 335 1643-1649.
61. Dunsavage MB, O'Leary CJ, Baumgart TD, Solvason N, Howard M, Lafferty K, Deshpande S & Reich EP 1999 A conformationally-constrained MHC class II I-ag7-derived peptide protects NOD mice from the development of diabetes. Journal of Autoimmunity 12 233-242.
62. Durant S, Coulaud J, Amrani A, el Hasnaoui A, Dardenne M & Homo-Delarche F 1993 Effects of various environmental stress paradigms and adrenalectomy on the expression of autoimmune type I diabetes in the non-obese diabetic (NOD) mouse. Journal of Autoimmunity 6 735-751.
63. Elliott JF, Qin HY, Bhatti S, Smith DK, Singh RK, Dillon T, Lauzon J & Singh B 1994 Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice. Diabetes 43 1494-1499.
64. Elliott RB, Reddy SN, Bibby NJ & Kida K 1988 Dietary prevention of diabetes in the non-obese diabetic mouse. Diabetologia 31 62-64.
65. Elliott RB, Pilcher CC, Stewart A, Fergusson D & McGregor MA 1993 The use of nicotinamide in the prevention of type I diabetes. Annals of the New York Academy of Sciences 696 333-341.
66. Emlen W, Niebur J & Kadera R 1994 Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. Journal of Immunology 152 3685-3692.
67. Fakir M, Penfornis A, Elian N, Cugnuene PH & Altman JJ 1997 Grafted immunoisolated human benign insulinoma reduces the incidence of diabetes in young NOD mice without abolishing the auto-immunity. International Journal of Artificial Organs 20 637-643.
68. Fan CM & Maniatis T 1991 Generation of p50 subunit of NF-κB by processing of p105 through an ATP-dependent pathway. Nature 354 395-398.
69. Faustman D, Eisenbarth G, Daley J & Breitmeyer J 1989 Abnormal T lymphocyte subsets in type I diabetes mellitus: analysis with anti-2 h4 and anti-4b4 antibodies. Diabetes 38 1462-1468.
70. Faustman D, Schoenfeld D & Ziegler R 1991 T-lymphocyte changes linked to autoantibodies: association of insulin autoantibodies with CD4+CD45R+ lymphocyte subpopulation in prediabetic subjects. Diabetes 40 590-597.
71. Feili-Hariri M, Frantz MO & Morel PA 2000 Prevention of diabetes in the NOD mouse by a TH1 clone specific for a HSP60 peptide. Journal of Autoimmunity 14 133-142.
72. Fitzpatrick F, Lepault F, Homo-Delarche F, Bach JF & Dardenne M 1991 Influence of castration, alone or combined with thymectomy, on the development of diabetes in the nonobese diabetic mouse. Endocrinology 129 1382-1390.
73. Formby B, Jacobs C, Dubuc P & Shao T 1992 Exogenous administration of IL-1α inhibits active and adoptive transfer autoimmune diabetes in NOD mice. Autoimmunity 12 21-27.
74. Foulis AK 1987 C L, Oakley lecture (1987). The pathogenesis of β cell destruction in type I (insulin-dependent) diabetes mellitus. Journal of Pathology 152 141-148.
75. Fox HS 1992 Androgen treatment prevents diabetes in nonobese diabetic mice. Journal of Experimental Medicine 175 1409-1412.
76. Franzoso G, Carlson L, Xing L, Poljak L, Shores EW, Brown KD, Leonardi A, Tran T, Boyce BF & Siebenlist U 1997 Requirement for NF-κB in osteoblast and B-cell development. Genes and Development 11 3482-3496.
77. Freland S, Chambers BJ, Andersson M, Van Kaer L & Ljunggren HG 1998 Rejection of allogeneic and syngeneic but not MHC class I-deficient tumor grafts by MHC class I-deficient mice. Journal of Immunology 160 572-579.
78. Fruh K, Yang Y, Arnold D, Chambers J, Wu L, Waters JB, Spies T & Peterson PA 1992 Alternative exon usage and processing of the major histocompatibility complex-encoded proteasome subunits. Journal of Biological Chemistry 267 22131-22140.
79. Fu Y, Nathan DM, Li F, Li X & Faustman DL 1993 Detective major histocompatibility complex class I expression on lymphoid cells in autoimmunity. Journal of Clinical Investigation 91 2301-2307.
80. Fujihira K, Nagata M, Moriyama H, Yasuda H, Arisawa K, Nakayama M, Maeda S, Kasuga M, Okumura K, Yagita H & Yokono K 2000 Suppression and acceleration of autoimmune diabetes by neutralization of endogenous interleukin-12 in NOD mice. Diabetes 49 1998-2006.
81. Funda DP, Hartoft-Nielsen ML, Kaas A & Buschard K 1998 Effect of intrathymic administration of mycobacterial heat shock protein 65 and peptide p277 on the development of diabetes in NOD mice: caution required in vaccination studies. Acta Pathologica, Microbiologica et Immunologica Scandinavica 106 1009-1016.
82. Funda DP, Kaas A, Bock T, Tlaskalova-Hogenova H & Buschard K 1999 Gluten-free diet prevents diabetes in NOD mice. Diabetes/Metabolism Research and Review 15 323-327.
83. Gaczynska M, Goldberg AL, Tanaka K, Hendil KB & Rock KL 1996 Proteasome subunits x and y alter peptidase activities in opposite ways to the interferon-γ-induced subunits LMP2 and LMP7. Journal of Biological Chemistry 271 17275-17280.
84. Gearon CL, Hussain MJ, Vergani D & Peakman M 1997 Lymphocyte vaccination protects prediabetic non-obese diabetic mice from developing diabetes mellitus. Diabetologia 40 1388-1395.
85. Ghosh S & Baltimore D 1990 Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB. Nature 344 678-682.
86. Glas R, Ohlen C, Hoglund P & Karre K 1994 The CD8+ T cell repertoire in β2-microglobulin-deficient mice is biased towards reactivity against self major histocompatibility class 1. Journal of Experimental Medicine 179 661-672.
87. Goldberg AL 1995 Function of the proteame: the lysis at the end of the tunnel (comment). Science 268 522-523.
88. Greeley SA, Katsumata M, Yu L, Eisenbarth GS, Moore DJ, Goodarzi H, Barker CF, Naji A & Noorchashm H 2002 Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nature Medicine 8 399-402.
89. Gregori S, Giarratana N, Smiroldo S, Uskokovic M & Adorini L 2002 A 1α,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 51 1367-1374.
90. Grillin TA, Naudi D, Cruz M, Fehling HJ, Van Kaer L, Monaco IJ & Colbert RA 1998 Immunoproteasome assembly: cooperative incorporation of interferon γ (IFN-γ)-inducible subunits. Journal of Experimental Medicine 187 97-104.
91. Gross DJ, Sidi H, Weiss L, Kalland T, Rosenmann E & Slavin S 1994 Prevention of diabetes mellitus in non-obese diabetic mice by linomide, a novel immunomodulating drug. Diabetologia 37 1195-1201.
92. Gross DJ, Weiss L, Reibstein I, van den Brand J, Okamoto H, Clark A & Slavin S 1998 Amelioration of diabetes in nonobese diabetic mice with advanced disease by linomide-induced immunoregulation combined with reg protein treatment. Endocrinology 139 2369-2374.
93. Haberstroh J, Wilhelm T, Schulte-Monting J, Schorlemmer HU & von Specht BU 1995 Prevention of type1 diabetes in the non-obese diabetic (NOD) mouse with 15-deoxyspergualin (15-ds) or 15-ds + cyclosporin a (cya). Immunology Letters 48 117-121.
94. Han HS, Jun HS, Utsugi T & Yoon JW 1997 Molecular role of TGF-β, secreted from a new type of CD4+ suppressor T cell, ny4-2, in the prevention of autoimmune IDDM in NOD mice. Journal of Autoimmunity 10 299-307.
95. Hanafusa T, Miyazaki A, Miyagawa J, Tamura S, Inada M, Yamada K, Shinji Y, Katsura H, Yamagata K & Itoh N 1990 Examination of islets in the pancreas biopsy specimens from newly diagnosed type I (insulin-dependent) diabetic patients. Diabetologia 33 105-111.
96. Harada M & Makino S 1986 Suppression of overt diabetes in NOD mice by anti-thymocyte serum or anti-thy 1,2 antibody. Jikken Dobutsu 35 501-504.
97. Harada M, Kishimoto Y & Makino S 1990 Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination. Diabetes Research and Clinical Practice 8 85-89.
98. Harrison LC, Dempsey-Collier M, Kramer DR & Takahashi K 1996 Aerosol insulin induces regulatory CD8γδ T cells that prevent murine insulin-dependent diabetes. Journal of Experimental Medicine 184 2167-2174.
99. Hasegawa Y, Yokono K, Taki T, Amano K, Tominaga Y, Yoneda R, Yagi N, Maeda S, Yagita H, Okumura K et al. 1994 Prevention of autoimmune insulin-dependent diabetes in non-obese diabetic mice by anti-LFA-1 and anti-ICAM-1 MAB. International Immunology 6 831-838.
100. Hawkins T, Gala RR & Dunbar JC 1993 The effect of neonatal sex hormone manipulation on the incidence of diabetes in nonobese diabetic mice. Proceedings of the Society for Experimental Biology and Medicine 202 201-205.
101. Hawkins TA, Gala RR & Dunbar JC 1994 Prolactin modulates the incidence of diabetes in male and female NOD mice. Autoimmunity 18 155-162.
102. Hayashi T & Faustman D 1999 NOD mice are defective in proteasome production and activation of NF-κB. Molecular and Cellular Biology 19 8646-8659.
103. Hayashi T & Faustman D 2000 Essential role of hla-encoded proteasome subunits in NF-κB activation and prevention of TNF-α induced apoptosis. Journal of Biological Chemistry 275 5238-5247.
104. Hayashi T, Sekine T & Okamoto T 1993a Identification of a new serine kinase that activates NF-κB by direct phosphorylation. Journal of Biological Chemistry 268 26790-26795.
105. Hayashi T, Ueno Y & Okamoto T 1993b Oxireductive regulation of nuclear factor κB, involvement of a cellular reducing catalyst thioredoxin. Journal of Biological Chemistry 268 11380-11388.
106. Hayward AR & Shreiber M 1989 Neonatal injection of CD3 antibody into nonobese diabetic mice reduces the incidence of insulitis and diabetes. Journal of Immunology 143 1555-1559.
107. Hayward AR, Cobbold SP, Waldmann H, Cooke A & Simpson E 1988 Delay in onset of insulitis in NOD mice following a single injection of CD4 and CD8 antibodies. Journal of Autoimmunity 1 91-96.
108. Hayward AR, Shriber M, Cooke A & Waldmann H 1993 Prevention of diabetes but not insulitis in NOD mice injected with antibody to CD4. Journal of Autoimmunity 6 301-310.
109. Heineke EW, Johnson MB, Dillberger JE & Robinson KM 1993 Antioxidant MDL 29,311 prevents diabetes in nonobese diabetic and multiple low-dose STZ-injected mice. Diabetes 42 1721-1730.
110. Hermitte L, Vialettes B, Naquet P, Atlan C, Payan MJ & Vague P 1990 Paradoxical lessening of autoimmune processes in nonobese diabetic mice after infection with the diabetogenic variant of encephalomyocarditis virus. European Journal of Immunology 20 1297-1303.
111. Hisamatsu H, Shimbara N, Saito Y, Kristensen P, Hendil KB, Fujiwara T, Takahashi E, Tanahashi N, Tamura T, Ichihara A & Tanaka K 1996 Newly identified pair of proteasomal subunits regulated reciprocally by interferon-γ. Journal of Experimental Medicine 183 1807-1816.
112. Horwitz BH, Scott ML, Cherry SR, Bronson RT & Baltimore D 1997 Failure of lymphopoiesis after adoptive transfer of NF-κB-deficient fetal liver cells. Immunity 6 765-772.
113. Hsu SC, Gavrilin MA, Lee HH, Wu CC, Han SH & Lai MZ 1999 NFκB-dependent Fas ligand expression. European Journal of Immunology 29 2948-2956.
114. Hu Y, Baud V, Delhase M, Zhang P, Deerinck T, Ellisman M, Johnson R & Karin M 1999 Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase (see comments). Science 284 316-320.
115. Huang SW, Luchetta R & Peck AB 1991 Pertussigen treatment retards, but fails to prevent, the development of type I, insulin-dependent diabetes mellitus (IDDM) in NOD mice. Autoimmunity 9 311-317.
116. Hutchings P & Cooke A 1998 Protection from insulin dependent diabetes mellitus afforded by insulin antigens in incomplete Freund's adjuvant depends on route of administration. Journal of Autoimmunity 11 127-130.
117. Ikehara S, Ohtsuki H, Good RA, Asamoto H, Nakamura T, Sekita K, Muso E, Tochino Y, Ida T, Kuzuya H et al. 1985 Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation. PNAS 82 7743-7747.
118. Imai S, Tezuka H & Fujita K 2001 A factor of inducing IgE from a filarial parasite prevents insulin-dependent diabetes mellitus in nonobese diabetic mice. Biochemical and Biophysical Research Communications 286 1051-1058.
119. Iotsova V, Caamano J, Loy J, Yang Y, Lewin A & Bravo R 1997 Osteopetrosis in mice lacking NF-κB1 and NF-κB2. Nature Medicine 3 1285-1289.
120. Ito A, Aoyanagi N & Maki T 1997 Regulation of autoimmune diabetes by interleukin 3-dependent bone marrow-derived cells in NOD mice. Journal of Autoimmunity 10 331-338.
121. Itoh A & Maki F 1996 Protection of nonobese diabetic mice from autoimmune diabetes by reduction of islet mass before insulitis. PNAS 93 11053-11056.
122. Itoh N, Imagawa A, Hanafusa T, Waguri M, Yamamoto K, Iwahashi H, Moriwaki M, Nakajima H, Miyagawa J, Namba M, Makino S, Nagata S, Kono N & Matsuzawa Y 1997 Requirement of fas for the development of autoimmune diabetes in nonobese diabetic mice. Journal of Experimental Medicine 186 613-618.
123. Jacob CO, Aiso S, Michie SA, McDevitt HO & Acha-Orbea H 1990 Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-α and interleukin I. PNAS 87 968-972.
124. Jansen A, Van Hagen M & Drexhage HA 1995 Defective maturation and function of antigen-presenting cells in type I diabetes. Lancet 345 491-492.
125. Kai N, Motojima K, Tsunoda T & Kanematsu T 1993 Prevention of insulitis and diabetes in nonobese diabetic mice by administration of FK506. Transplantation 55 936-940.
126. Kaino Y, Hirai H, Ito T & Kida K 1998 Prevention of diabetes in non-obese diabetic (NOD) mice by short-term and high-dose IGF-I treatment. Journal of Pediatric Endocrinology and Metabolism 11 267-272.
127. Kanegae Y, Ransone LJ, Wamsley P, Schmitt MJ, Boyer TG, Zhou Q, Berk AJ & Verma IM 1998 Role of Rcl/NF-κB transcription factors during the outgrowth of the vertebrate limb. Nature 392 611-614.
128. Kang SM, Schneider DB, Lin Z, Hanahan D, Dichek DA, Stock PG & Baekkeskov S 1997 Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction (see comments). Nature Medicine 3 738-743.
129. Kang SM, Lin Z, Ascher NL & Stock PG 1998 Fas ligand expression on islets as well as multiple cell lines results in accelerated neutrophilic rejection. Transplantation Proceedings 30 538.
130. Karges W, Hammond-McKibben D, Cheung RK, Visconti M, Shibuya N, Kemp D & Dosch HM 1997 Immunological aspects of nutritional diabetes prevention in NOD mice: A pilot study for the cow's milk-based IDDM prevention trial. Diabetes 46 557-564.
131. Karounos DG, Bryson JS & Cohen DA 1997 Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice. Journal of Clinical Investigation 100 1344-1348.
132. Kawamura T, Nagata M, Utsugi T & Yoon JW 1993 Prevention of autoimmune type I diabetes by CD4+ suppressor T cells in superantigen-treated nonobese diabetic mice. Journal of Immunology 151 4362-4370.
133. Kay TWH, Campbell IL, Oxbrow L & Harrison LC 1991 Overexpression of class I major histocompatibility complex accompanies insulitis in the nonobese diabetic mouse and is prevented by anti-interferon-γ antibody. Diabetologia 34 779-785.
134. Khan NA, Khan A, Savelkoul HF & Benner R 2001 Inhibition of diabetes in NOD mice by human pregnancy factor. Human Immunology 62 1315-1323.
135. Kim JY, Chi JK, Kim EJ, Park SY, Kim YW & Lee SK 1997 Inhibition of diabetes in non-obese diabetic mice by nicotinamide treatment for 5 weeks at the early age. Journal of Korean Medical Science 12 293-297.
136. Kim JY, Cho SH, Kim YW, Jang EC, Park SY, Kim EJ & Lee SK 1999a Effects of BCG lymphotoxin and bee venom on insulitis and development of IDDM in non-obese diabetic mice. Journal of Korean Medical Science 14 648-652.
137. Kim S, Kim KA, Hwang DY, Lee TH, Kayagaki N, Yagita H & Lee MS 2000 Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved. Journal of Immunology 164 2931-2936.
138. Kim YH, Kim S, Kim KA, Yagita H, Kayagaki N, Kim KW & Lee MS 1999b Apoptosis of pancreatic beta-cells detected in accelerated diabetes of NOD mice: no role of fas-fas ligand interaction in autoimmune diabetes. European Journal of Immunology 29 455-465.
139. Klandorf H, Chirra AR, DeGruccio A & Girman DJ 1989 Dimethyl sulfoxide modulation of diabetes onset in NOD mice. Diabetes 38 194-197.
140. Ko KS, Lee M, Koh JJ & Kim SW 2001 Combined administration of plasmids encoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice. Molecular Therapy 4 313-316.
141. Kobayashi T, Song QH, Hong T, Kitamura H & Cyong JC 2000 Preventive effect of ninjin-to (ren-shen-tang), a kampo (Japanese traditional) formulation, on spontaneous autoimmune diabetes in non-obese diabetic (NOD) mice. Microbiological Immunology 44 299-305.
142. Koike T, Itoh Y, Ishii I, Ito I, Takabayashi K, Maruyama N, Tomioka H & Yshida S 1987 Preventive effect of monoclonal anti-13t4 antibody on development of diabetes in NOD mice. Diabetes 36 539-541.
143. Kontgen F, Grumont RJ, Strasser A, Metcalf D, Li R, Tarlinton D & Gerondakis S 1995 Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes and Development 9 1965-1977.
144. Koshy M, Berger D & Crow MK 1996 Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. Journal of Clinical Investigation 98 826-837.
145. Kovacs B, Liossis SN, Dennis GJ & Tsokos GC 1997 Increased expression of functional fas-ligand in activated T cells from patients with systemic lupus erythematosus. Autoimmunity 25 213-221.
146. Krause I, Tomer Y, Elias D, Blank M, Gilburd B, Cohen IR & Shoenfeld Y 1999 Inhibition of diabetes in NOD mice by idiotypic induction of SLE. Journal of Autoimmunity 13 49-55.
147. Lamhamedi-Cherradi SE, Luan JJ, Eloy L, Fluteau G, Bach JF & Garchon HJ 1998 Resistance of T-cells to apoptosis in autoimmune diabetic (NOD) mice is increased early in life and is associated with dysregulated expression of bcl-x. Diabetologia 41 178-184.
148. Lee K, Amano K & Yoon J 1988 Evidence for initial involvement of macrophage in development of insulitis in NOD mice. Diabetes 37 989-991.
149. Lee M, Koh JJ, Han SO, Ko KS & Ki SW 2002 Prevention of autoimmune insulitis by delivery of interleukin-4 plasmid using a soluble and biodegradable polymeric carrier. Pharmaceutical Research 19 246-249.
150. Leiter EH & Atkinson MA 1998 NOD mice and related strains: Research applications in diabetes, aids, cancer and other diseases. Medical intelligence unit. Jackson Laboratory Newsletter.
151. Lenschow DJ, Ho SC, Sattar H, Rhee L, Gray G, Nabavi N, Herold KC & Bluestone JA 1995 Differential effects of anti-b7-1 and anti-b7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. Journal of Experimental Medicine 181 1145-1155.
152. Lepault F, Gagnerault MC, Faveeuw C, Bazin H & Boitard C 1995 Lack of L-selectin expression by cells transferring diabetes in NOD mice: insights into the mechanisms involved in diabetes prevention by mel-14 antibody treatment. European Journal of Immunology 25 1502-1507.
153. Li F, Hauser SL, Linan MJ, Stein MC & Faustman DL 1995 Reduced expression of peptide-loaded HLA class I molecules on multiple sclerosis lymphocytes. Annals of Neurology 38 147-151.
154. Li H, Kaufman CL, Boggs SS, Johnson PC, Patrene KD & Ildstad ST 1996 Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice. Journal of Immunology 156 380-388.
155. Li Q, Lu Q, Hwang JY, Buscher D, Lee KF, Izpisua-Belmonte JC & Verma IM 1999a IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes and Development 13 1322-1328.
156. Li Q, Van Antwerp D, Mercurio F, Lee KF & Verma IM 1999b Severe liver degeneration in mice lacking the IκB kinase 2 gene (see comments). Science 284 321-325.
157. Li X & Faustman D 1993 Use of donor β2-microglobulin-deficient transgenic mouse liver cells for isografts, allografts, and xenografts. Transplantation 55 940-946.
158. Liang H & Fesik SW 1997 Three-dimensional structures of proteins involved in programmed cell death. Journal of Molecular Biology 274 291-302.
159. Liang L, Beshay F & Prud'homme GJ 1998 The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice. Diabetes 47 570-575.
160. Liddi R, Beales PE, Rosignoli G & Pozzilli P 2000 Incomplete Freund's adjuvant reduces diabetes in the non-obese diabetic mouse. Homone and Metabolic Research 32 201-206.
161. Lin J, Tserng K, Chen C, Lin L & Tung T 1970 Abrin and ricin: new anti-tumor substances. Nature 227 292-293.
162. Lin L, De Martino GN & Greene WC 1998 Co-translational biogenesis of NF-κB p50 by the 26S proteasome. Cell 92 819-828.
163. Lorenz HM, Grunke M, Hieronymus T, Herrmann M, Kuhnel A, Manger B & Kalden JR 1997 In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases (see comments). Arthritis and Rheumatism 40 306-317.
164. Lynch DH, Watson ML, Alderson MR, Baum PR, Miller RE, Tough T, Gibson M, Davis-Smith T, Smith CA & Hunter K 1994 The mouse fas-ligand gene is mutated in GLD mice and is part of a TNF family gene cluster. Immunity 1 131-136.
165. Mabley JG, Pacher P, Southan GJ, Salzman AL & Szabo C 2002 Nicotine reduces the incidence of type I diabetes in mice. Journal of Pharmacological and Experimental Therapy 300 876-881.
166. McDevitt HO 1995 Autoimmune diabetes and its antigenic triggers. Hospital Practice (Office Edition) 30 55-62.
167. McInerney MF, Pek SB & Thomas DW 1991 Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice. Diabetes 40 715-725.
168. MacKichan ML, Logeat F & Israel A 1996 Phosphorylation of p105 pest sequences via a redox-insensitive pathway up-regulates processing of p50 NF-κB. Journal of Biological Chemistry 271 6084-6091.
169. Maki T, Ichikawa T, Blanco R & Porter J 1992 Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum. PNAS 89 3434-3438.
170. Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K & Tochino Y 1980 Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 29 1-13.
171. Makino S, Kunimoto K, Muraoka Y & Katagiri K 1981 Effect of castration on the appearance of diabetes in NOD mouse. Jikken Dobutsu 30 137-140.
172. Mandel TE, Koulmanda M & Mackay IR 1992 Prevention of spontaneous and cyclophosphamide-induced diabetes in non-obese diabetic (NOD) mice with oral 2-acetyl-4-tetrahydroxybutylimidazole (THI), a component of caramel colouring III. Clinical and Experimental Immunology 88 414-419
173. Maniatis T 1999 A ubiquitin ligase complex essential for the NF-κB, wnt/wingless, and hedgehog signaling pathways. Genes and Development 13 505-510.
174. Maron R, Melican NS & Weiner HL 1999 Regulatory TH2-type T cell lines against insulin and gad peptides derived from orally- and nasally-treated NOD mice suppress diabetes. Journal of Autoimmunity 12 251-258.
175. Matarese G, Sanna V, Lechler RI, Sarvetnick N, Fontana S, Zappacosta S & La Cava A 2002 Leptin accelerates autoimmune diabetes in female NOD mice. Diabetes 51 1356-1361.
176. Mathieu C, Waer M, Laureys J, Rutgeerts O & Bouillon R 1994 Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia 37 552-558.
177. Matsuzaki T, Nagata Y, Kado S, Uchida K, Kato I, Hashimoto S & Yokokura T 1997 Prevention of onset in an insulin-dependent diabetes mellitus model. NOD mice, by oral feeding of Lactobacillus casei. Acta Pathologica, Microbiologica et Immunologica Scandinavica 105 643-649.
178. Menard V, Jacobs H Jun HS, Yoon JW & Kim SW 1999 Anti-gad monoclonal antibody delays the onset of diabetes mellitus in NOD mice. Pharmaceutical Research 16 1059-1066.
179. Mori Y, Suko M, Okudaira H, Matsuba I, Tsuruoka A, Sasaki A, Yokoyama H, Tanase T, Shida T, Nishimura M et al. 1986 Preventive effects of cyclosporin on diabetes in NOD mice. Diabetologia 29 244-247.
180. Mountz JD, Zhou T, Su X, Cheng J, Pierson M, Bluethmann H & Edwards CK 3rd 1996 Autoimmune disease results from multiple interactive defects in apoptosis induction molecules and signaling pathways. Behring Institute Mitteilungen 97 200-219.
181. Mysler E, Bini P, Drappa J, Ramos P, Friedman SM, Krammer PH & Elkon KB 1994 The apoptosis- 1/fas protein in human systemic lupus erythematosus. Journal of Clinical Investigation 93 1029-1034.
182. Nakajima H, Tochino Y, Fujino-Kurihara H, Yamada K, Gomi M, Tajima K, Kanaya T, Miyazaki A, Miyagawa J, Hanafusa T et al. 1985 Decreased incidence of diabetes mellitus hy monosodium glutamate in the non-obese diabetic (NOD) mouse. Research Communications in Chemical Pathology and Pharmacology 50 251-257.
183. Neri A, Chang CC, Lombardi I, Salina M, Corradini P, Maiolo AT, Chaganti RS & Dalla-Favera R 1991 B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50. Cell 67 1075-1087.
184. Nicoletti F, Di Marco R, Barcellini W, Magro G, Schorlemmer HU, Kurrle R, Lunetta M, Grasso S, Zaccone P & Meroni P 1994 Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor. European Journal of Immunology 24 1843-1847.
185. Nicoletti F, Zaccone P, Di Marco R, Magro G, Grasso S, Morrone S, Santoni A, Tempera G, Meroni PL & Bendtzen K 1995 Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock. Immunology 85 645-650.
186. Nicoletti F, Zaccone P, Di Marco R, Di Mauro M, Magro G, Grasso S, Mughini L, Meroni P & Garotta G 1996 The effects of a nonimmunogenic form of murine soluble interferon-γ receptor on the development of autoimmune diabetes in the NOD mouse. Endocrinology 137 5567-5575.
187. Nicoletti F, Zaccone P, Conger I, Gomis R, Moller C, Meroni PL, Bendtzen K, Trepicchio W & Sandler S 1999 Early prophylaxis with recombinant human interleukin-11 prevents spontaneous diabetes in NOD mice. Diabetes 48 2333-2339.
188. Nitta Y, Kawamoto S, Tashiro F, Aihara H, Yoshimoto T, Nariuchi H, Tabayashi K & Miyazaki J 2001 IL-12 plays a pathologic role at the inflammatory loci in the development of diabetes in NOD mice. Journal of Autoimmunity 16 97-104.
189. Nomaguchi H, Yogi Y, Kawatsu K, Okamura H, Ozawa Y & Kasatani T 2002 Prevention of diabetes in non-obese diabetic mice by a single immunization with Mycobacterium leprae. Nihon Hansenbyo Gakkai Zasshi 71 31-38.
190. O'Hara RM Jr, Henderson SL & Nagelin A 1996 Prevention of a TH1 disease by a TH1 cytokine: IL-12 and diabetes in NOD mice. Annals of the New York Academy of Sciences 795 241-249.
191. Oldstone MB 1988 Prevention of type I diabetes in nonobese diabetic mice by virus infection. Science 239 500-502.
192. Oldstone MBA 1990 Viruses as therapeutic agents. I Treatment of nonobese insulin-dependent diabetes mice With virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence. Journal of Experimental Medicine 171 2077-2089.
193. Ono SJ, Issa-Chergui B, Colle E, Guttmann RD, Seemayer TA & Fulks A 1988 IDDM in BB rats. Enhanced MHC class I heavy-chain gene expression in pancreatic islets. Diabetes 37 1411-1418.
194. Ouaaz F, Li M & Beg AA 1999 A critical role for the rela subunit of nuclear factor κB in regulation of multiple immune-response genes and in fas-induced cell death. Journal of Experimental 189 999-1004.
195. Pacheco-Silva A, Bastos MG, Muggia RA, Pankewycz O, Nichols J, Murphy JR, Strout TB & Rubin-Kelley VE 1992 Interleukin 2 receptor targeted fusion toxin (dab486-IL-2) treatment blocks diabetogenic autoimmunity in non-obese diabetic mice. European Journal of Immunology 22 697-702.
196. Pakala SV, Chivetta M, Kelly CB & Katz JD 1999 In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha. Journal of Experimental Medicine 189 1053-1062.
197. Palombella V, Rando OJ, Goldberg AL & Maniatis T 1994 The ubiquitin proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78 773-785.
198. Panerai AEi, Nicoletti F, Sacedote P, Arvidsson L, Conget I, Gomis R, Bartorelli A & Sandler S 2001 Mfp14, a multifunctional emerging protein with immunomodulatory properties, prevents spontaneous and recurrent autoimmune diabetes in NOD mice. Diabetologia 44 839-847.
199. Papaccio G, Nicoletti F, Pisanti FA, Bendtzen K & Galdieri M 2000 Prevention of spontaneous autoimmune diabetes in NOD mice by transferring in vitro antigen-pulsed syngeneic dendritic cells. Endocrinology 141 1500-1505.
200. Pennline KJ, Roque-Gaffney E & Monahan M 1994 Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clinical Immunology and Immunopathology 71 169-175.
201. Peterson KP, Van Hirtum M & Peterson CM 1997 Dapsone decreases the cumulative incidence of diabetes in non-obese diabetic female mice. Proceedings of the Society for Experimental Biology and Medicine 215 264-268.
202. Piccirillo CA, Chang Y & Prud'homme GJ 1998 TGF-β1 somatic gene therapy prevents autoimmune disease in nonobese diabetic mice. Journal of Immunology 161 3950-3956.
203. Pleau JM, Fernandez-Saravia F, Esling A, Homo-Delarche F & Dardenne M 1995 Prevention of autoimmune diabetes in nonobese diabetic female mice by treatment with recombinant glutamic acid decarboxylase (GAD 65). Clinical Immunology and Immunopathology 76 90-95.
204. Ploix C, Bergerot I, Fabien N, Perche S, Moulin V & Thivolet C 1998 Protection against autoimmune diabetes with oral insulin is associated with the presence of IL-4 type 2 T-cells in the pancreas and pancreatic lymph nodes. Diabetes 47 39-44.
205. Ploix C, Bergerot I, Durand A, Czerkinsky C, Holmgren J & Thivolet C 1999 Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD+ regulatory T-cells. Diabetes 48 2150-2156.
206. Polanski M, Melican NS, Zhang J & Weiner HL 1997 Oral administration of the immunodominant B-chain of insulin reduces diabetes in a co-transfer model of diabetes in the NOD mouse and is associated with a switch from Th1 to Th2 cytokines. Journal of Autoimmunity 10 339-346.
207. Poligone B, Weaver DJ Jr, Sen P, Baldwin AS Jr & Tisch R 2002 Elevated NF-κB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function. Journal of Immunology 168 188-196.
208. Rabinovitch A 1998 An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes/Metabolism Review 14 129-151.
209. Rabinovitch A & Skyler JS 1998 Prevention of type I diabetes. Medical Clinics of North America 82 739-755.
210. Rabinovitch A, Suarez WL & Power RF 1992 Combination therapy with an antioxidant and a corticosteroid prevents autoimmune diabetes in NOD mice. Life Science 51 1937-1943.
211. Rabinovitch A, Suarez WL & Power RF 1993 Lazaroid antioxidant, reduces incidence of diabetes and insulitis in nonobese diabetic mice. Journal of Laboratory and Clinical Medicine 121 603-607.
212. Ramiya VK, Shang XZ, Pharis PG, Wasserfall CH, Stabler TV, Muir AB, Schatz DA & Maclaren NK 1996 Antigen based therapies to prevent diabetes in NOD mice. Journal of Autoimmunity 9 349-356.
213. Ramiya VK, Shang XZ, Wasserfall CH & Maclaren NK 1997 Effect of oral and intravenous insulin and glutamic acid decarboxylase in NOD mice. Autoimmunity 26 139-151.
214. Ramsdell F, Seaman MS, Miller RE, Tough TW, Alderson MR & Lynch DH 1994 Gld/gld mice are unable to express a functional ligand for fas. European Journal of Immunology 24 928-933.
215. Rapoport MJ , Jaramillo A, Zipris D, Lazarus AH, Serreze DV, Leiter EH, Cyopick P, Danska JS & Delovitch TL 1993 Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. Journal of Experimental Medicine 178 87-99.
216. Reddy S, Bibby NJ, Wu D, Swinney C, Barrow G & Elliott RB 1995 A combined casein-free-nicotinamide diet prevents diabetes in the NOD mouse with minimum insulitis. Diabetes Research and Clinical Practice 29 83-92.
217. Reddy S, Stefanovic N & Karanam M 2000 Prevention of autoimmune diabetes by oral administration of syngeneic pancreatic extract to young NOD mice. Pancreas 20 55-60.
218. Reich EP, Scaringe D, Yagi J, Sherwin RS & Janeway CA 1989 Prevention of diabetes in NOD mice by injection of autoreactive T-lymphocytes. Diabetes 38 1647-1651.
219. Restifo NP 2000 Not so fas: re-evaluating the mechanisms of immune privilege and tumor escape. Nature Medicine 6 493 495.
220. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin KM, Fischer A & de Villartay JP 1995 Mutations in fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268 1347-1349.
221. Rothe H, Hausmann A, Casteels K, Okamura H, Kurimoto M, Burkart V, Mathieu C & Kolb H 1999 IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis. Journal of Immunology 163 1230-1236.
222. Rudolph D, Yeh WC, Wakeham A, Rudolph B, Nallainatham D, Potter J, Elia AJ & Mak TW 2000 Severe liver degeneration and lack of NF-κB activation in nemo/IKKγ-deficient mice. Genes and Development 14 854-862.
223. Ryu S, Kodama S, Ryu K, Schoenfeld DA & Faustman DL 2001 Reversal of established autoimmune diabetes by restoration of endogenous beta cell function. Journal of Clinical Investigation 108 63-72.
224. Sadelain MWJ, Hui-Yu Q, Lauzon J & Singh B 1990 Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes 39 583-589.
225. Sai P & Rivereau AS 1996 Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments. Comparative efficiency of human insulin and two bacterial antigens, lipopolysacharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae. Diabetes Metabolism 22 341-348.
226. Sai P, Senecat O, Martignat I, & Gouin E 1994 Neonatal injections of cyclosporin enhance autoimmune diabetes in non-obese diabetic mice. Clinical and Experimental Immunology 97 138-145.
227. Sai P, Damage C, Rivereau AS, Hoeltzel A & Gouin E 1996 Prophylactic oral administration of metabolically active insulin entrapped in isobutyleyanoacrylate nanocapsules reduces the incidence of diabetes in nonobese diabetic mice. Journal of Autoimmunity 9 713-722.
228. Saravia-Fernandez F, Durant S, el Hasnaoui A, Dardenne M & Homo-Delarche F 1996 Environmental and experimental procedures leading to variations in the incidence of diabetes in the nonobese diabetic (NOD) mouse. Autoimmunity 24 113-121.
229. Satoh J, Seino H, Shintani S, Tanaka S, Ohteki T, Masuda T, Nobunaga T & Toyota T 1990 Inhibition of type I diabetes in BB rats with recombinant human tumor necrosis factor-α. Journal of Immunology 145 1395-1399.
230. Schmid RM, Perkins ND, Duckett CS, Andrews PC & Nabel GJ 1991 Cloning of an NF-κB subunit which stimulates HIV transcription in synergy with p65. Nature 352 733-736.
231. Schneider K, Laube H & Linn T 1996 A diet enriched in protein accelerates diabetes manifestation in NOD mice. Acta Diabetologia 33 236-240.
232. Sears C, Olesen J, Rubin D, Finley D & Maniatis T 1998 NF-κB p105 processing via the ubiquitin-proteasome pathway. Journal of Biological Chemistry 273 1409-1419.
233. Seino H, Satoh J, Shintani S, Takahashi K, Zhu XP, Masuda T, Nobunaga T, Saito M, Terano Y & Toyota T 1991 Inhibition of autoimmune diabetes in NOD mice with serum from streptococcal preparation (OK-432)-injected mice. Clinical and Experimental Immunology 86 413-418.
234. Seino H, Takahashi K, Satoh J, Zhu XP, Sagara M, Masuda T, Nobunaga T, Funahashi L, Kajikawa T & Toyota T 1993 Prevention of autoimmune diabetes with lymphotoxin in NOD mice. Diabetes 42 398-404.
235. Serreze DV, Hamaguchi K & Leiter EH 1989 Immunostimulation circumvents diabetes in NOD/lt mice. Journal of Autoimmunity 2 759-776.
236. Sha WC, Liou HC, Tuomanen EI & Baltimore D 1995 Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80 321-330.
237. Shapiro AM, Suarez-Pinzon WL, Power R & Rabinovitch A 2002 Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice. Diabetologia 45 224-230.
238. Sharif S, Arreaza GA, Zucker P, Mi QS, Sondhi J, Naidenko OV, Kronenberg M, Koezuka Y, Delovitch TL, Gombert JM, Leite-De-Moraes M, Gouarin C, Zhu R, Hameg A, Nakayama T, Taniguchi M, Lepault F, Lehuen A, Bach JF & Herbelin A 2001 Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune type I diabetes. Nature Medicine 7 1057-1062.
239. Shehadeh N, Etzioni A, Cabana A, Teninboum G, Gorodetsky B, Barzilai D & Karnieli F 1997 Repeated BCG vaccination is more effective than a single dose in preventing diabetes in non-obese diabetic (NOD) mice. Israel Journal of Medical Sciences 33 711-715.
240. Shimada A, Takei I, Maruyama T, Kasuga A, Kasatani T, Watanabe K, Asaba Y, Ishii T, Tadakuma T, Habu S et al. 1994 Acceleration of diabetes in young NOD mice with peritoneal macrophages. Diabetes Research and Clinical Practice 24 69-76.
241. Smerdon RA, Peakman M, Hussain MJ, Alviggi L, Watkins PJ, Leslie DG & Vergani D 1993 Increase in simultaneous coexpression of naive and memory lymphocyte markers at diagnosis of IDDM. Diabetes 42 127-133.
242. Snapper GM, Zelazowski P, Rosas FR, Kehry MR, Tian M, Baltimore D & Sha WC 1996 B cells from p50/NF-κB knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. Journal of Immunology 156 183-191.
243. Sobel DO & Ahvazi B 1998 Alpha-interferon inhibits the development of diabetes in NOD mice. Diabetes 47 1867-1872.
244. Sobel DO, Yankelevich B, Goyal D, Nelson D & Mazumder A 1998 The b-subunit of cholera toxin induces immunoregulatory cells and prevents diabetes in the NOD mouse. Diabetes 47 186-191.
245. Stephens LA, Thomas HE & Kay TW 1997 Protection of nit-1 pancreatic beta-cells from immune attack by inhibition of NF-κB. Journal of Autoimmunity 10 293-298.
246. Suarez-Pinzon W, Sorensen O, Bleackley RC, Elliott JF, Rajotte RV & Rabinovitch A 1999 Beta-cell destruction in NOD mice correlates with fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets. Diabetes 48 21-28.
247. Suarez-Pinzon WL, Mabley JG, Strynadka K, Power RF, Szabo C & Rabinovitch A 2001 An inhibitor of inducible nitric oxide synthase and scavenger of peroxynitrite prevents diabetes development in NOD mice. Journal of Autoimmunity 16 449-455.
248. Sun SC, Ganchi PA, Beraud C, Ballard DW & Greene WC 1994 Autoregulation of the NF-κB transactivator rela (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs. PNAS 91 1346-1350.
249. Takahashi M, Kojima S, Yamaoka K & Niki E 2000 Prevention of type I diabetes by low-dose gamma irradiation in NOD mice. Radiation Research 154 680-685.
250. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T & Nagata S 1994 Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand. Cell 76 969-976.
251. Takeda K, Takeuchi O, Tsujimura T, Itami S, Adachi O, Kawai T, Sanjo H, Yoshikawa K, Terada N & Akira S 1999 Limb and skin abnormalities in mice lacking IKKα (see comments). Science 284 313-316.
252. Takei I, Asaba Y, Kassatani T, Maruyama T, Watanabe K, Yanagawa T, Saruta T & Ishii T 1992 Suppression of development of diabetes in NOD mice by lactate dehydrogenase virus infection. Journal of Autoimmunity 5 665-674.
253. Tan TH, Huang GP, Sica A, Ghosh P, Young HA, Longo DL & Rice NR 1992 κB site-dependent activation of the interleukin-2 receptor alpha-chain gene promoter by human c-Rel. Molecular and Cellular Biology 12 4067-4075.
254. Tanaka M, Fuentes ME, Yamaguchi K, Durnin MH, Dalrymple SA, Hardy KL & Goeddel DV 1999 Embryonic lethality, liver degeneration, and impaired NF-κB activation in IKK-β-deficient mice. Immunity 10 421-429.
255. Tanaka-Kataoka M, Kunikata T, Takayama S, Iwaki K, Fujii M, Ohashi K, Ikeda M & Kurimoto M 1999 Oral use of interferon-alpha delays the onset of insulin-dependent diabetes mellitus in nonobese diabetes mice. Journal of Interferon and Cytokine Research 19 877-879.
256. Thanos D & Maniatis T 1995 NF-κB: a lesson in family values. Cell 80 529-532.
257. Thomas HE, Darwiche R, Corbett JA & Kay TW 1999 Evidence that beta cell death in the nonobese diabetic mouse is fas independent. Journal of Immunology 163 1562-1569.
258. Tian J, Atkinson MA, Clare-Salzler M, Herschenfeld A, Forsthuber T, Lehmann PV & Kaufman DL 1996 Nasal administration of glutamate decarboxylase (Gad65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. Journal of Experimental Medicine 183 1561-1567.
259. Timsit J, Savino W, Boitard C & Bach JF 1989 The role or class II major histocompatibility complex antigens in autoimmune diabetes: animal models. Journal of Autoimmunity 2 (Suppl) 115-129.
260. Tisch R, Yang XDi Singer SM, Liblau RS, Fugger L & McDevitt HO 1993 Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366 72-75.
261. Tisch R, Yang XD, Liblau RS & McDevitt HO 1994 Administering glutamic acid decarboxylase to NOD mice prevents diabetes. Journal of Autoimmunity 7 845-850.
262. Tisch R, Liblau RS, Yang XD, Liblau P & McDevitt HO 1998 Induction of gad65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice. Diabetes 47 894-899.
263. Tisch R, Wang B & Serreze DV 1999 Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent. Journal of Immunology 163 1178-1187.
264. Tominaga Y, Nagata M, Yasuda H, Okamoto N, Arisawa K, Moriyama H, Miki M, Yokono K & Kasuga M 1998 Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice. Clinical Immunology and Immunopathology 86 209-218.
265. Toyota F, Satoh J, Oya K, Shintani S & Okano T 1986 Streptococcal preparation (OK-432) inhibits development of type I diabetes in NOD mice. Diabetes 35 496-499.
266. Uehara Y, Shimizu H, Sato N, Shimomura Y, Mori M & Kobayashi I 1991 Probucol partially prevents development of diabetes in NOD mice. Diabetes Research 17 131-134.
267. Urbanek-Ruiz I, Ruiz PJ, Paragas V, Garren H, Steinman L & Fathman CG 2001 Immunization with DNA encoding an immunodominant peptide of insulin prevents diabetes in NOD mice. Clinical Immunology 100 164-171.
268. Van Antwerp DJ, Martin SJ, Kafri T, Green DR & Verma IM 1996 Suppression of TNF-α-induced apoptosis by NF-κB. Science 274 787-880.
269. Van Kaer L, Ashton-Rickardt PG, Eichelberger M, Gaczynska M, Nagashima K, Rock KL, Goldberg AL, Doherty PC & Tonegawa S 1994 Altered peptidase and viral-specific T cell response in lmp-2 mutant mice. Immunity 1 533-541.
270. Verma IM, Stevenson EM, Schwarz DV, Antwerp S & Miyamoto S 1995 Rel/NF-αB/IκB family: intimate tales of association and dissociation. Genes and Development 9 2723-2735.
271. Vidal-Puig A & Faustman DL 1994 Tolerance to peripheral tissue is transient and maintained by tissue specific class I expression. Transplantation Proceedings 26 3314-3316.
272. Vives-Pi M, Armengol MP, Alcalde L, Costa M, Somoza N, Vargas F, Jaraquemada D & Pujol-Borrell R 1996 Expression of transporter associated with antigen processing-1 in the endocrine cells of human pancreatic islets: effect of cytokines and evidence of hyperexpression in IDDM. Diabetes 45 779-788.
273. Wakatsuki Y, Neurath MF, Max EE & Strober W 1994 The B cell-specific transcription factor BSAP regulates B cell proliferation. Journal of Experimental Medicine 179 1099-1108.
274. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV & Boldin MP 1999 Tumor necrosis factor receptor and fas signaling mechanisms. Annual Review of Immunology 17 331-367.
275. Wang B, Gonzalez A, Benoist C & Mathis D 1996a The role of CD8+ T cells in the initiation of insulin-dependent diabetes mellitus. European Journal of Immunology 26 1762-1769.
276. Wang B, Geng YB & Wang CR 2001 CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes. Journal of Experimental Medicine 194 313-320.
277. Wang CY, Mayo MW & Baldwin AS 1996b TNF-and cancer therapy-induced apoptosis potentiation by inhibition of NF-κB. Science 274 784-787.
278. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA & Nagata S 1992 Lymphoproliferation disorder in mice explained by defects in fas antigen that mediates apoptosis. Nature 356 314-317.
279. Watson ML, Rao JK, Gilkeson GS, Ruiz P, Eicher EM, Pisetsky DS, Matsuzawa A, Rochelle JM & Seldin MF 1992 Genetic analysis of mrl-1pr mice: relationship of the fas apoptosis gene to disease manifestations and renal disease-modifying loci. Journal of Experimental Medicine 176 1645-1656.
280. Weaver DJ Jr, Liu B & Tisch R 2001 Plasmid DNAs encoding insulin and glutamic acid decarboxylase 65 have distinct effects on the progression of autoimmune diabetes in nonobese diabetic mice. Journal of Immunology 167 586-592.
281. Weih F, Carrasco D, Durham SK, Barton DS, Rizzo CA, Ryseck RP, Lira SA & Bravo R 1995 Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of relb, a member of the NF-κB/Rel family. Cell 80 331-340.
282. Weringer EJ & Like AA 1988 Identification of T cell subsets and class I and class II antigen expression in islet grafts and pancreatic islets of diabetic biobreeding/Worcester rat. American Journal of Pathology 132 292-303.
283. Wilberz S, Partke HJ, Dagnaes-Hansen F & Herberg L 1991 Persistent MHV (mouse hepatitis virus) infection reduces the incidence of diabetes mellitus in non-obese diabetic mice. Diabetologia 34 2-5.
284. Williams AJ, Krug J, Lampeter EF, Mansfield K, Beales PE, Signore A, Gale EA & Pozzilli P 1990 Raised temperature reduces the incidence of diabetes in the NOD mouse. Diabetologia 33 635-637.
285. Williams AJ, Beales PE, Krug J, Procaccini E, Signore A, Xu S, Gale EA & Pozzilli P 1993 Tolbutamide reduces the incidence of diabetes mellitus, but not insulitis, in the non-obese-diabetic mouse. Diabetologia 36 487-492.
286. Wilson SS, White TC & DeLuca D 2001 Therapeutic alteration of insulin-dependent diabetes mellitus progression by T cell tolerance to glutamic acid decarboxylase 65 peptides in vitro and in vivo. Journal of Immunology 167 569-577.
287. Wong HK, Kammer GM, Dennis G & Tsokos GC 1999 Abnormal NF-κB activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-rela protein expression. Journal of Immunology 163 1682-1689.
288. Wu J, Wilson J, He J, Xiang L, Schur PH & Mountz JD 1996a Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. Journal of Clinical Investigation 98 1107-1113.
289. Wu M, Lee H, Bellas RE, Schauer SL, Arsura M, Katz D, Fitzgerald MJ, Rothstein TL, Sherr DH & Sonenshein GE 1996b Inhibition of NF-κB/rel induces apoptosis of murine B cells. EMBO Journal 15 4682-4690.
290. Yamada K, Nonaka K, Hanafusa T, Miyazaki A, Toyoshima H & Tarui S 1982 Preventive and therapeutic effects of large-close nicotinamide injections on diabetes associated with insulitis. An observation in nonobese diabetic (NOD) mice. Diabetes 31 749-753.
291. Yan G, Fu Y & Faustman DL 1997 Reduced expression of TAP and LMP2 antigen processing genes in the nonobese diabetic (NOD) mouse due to a mutation in their shared bidirectional promoter. Journal of Immunology 159 3068-3080.
292. Yang XD, Michie SA, Tisch R, Karin N, Steinman L & McDevitt HO 1994a A predominant role of integrin α4 in the spontaneous development of autoimmune diabetes in nonobese diabetic mice. PNAS 91 12604-12608.
293. Yang XD, Tisch R, Singer SM, Cao ZA, Liblau RS, Schreiber RD & McDevitt HO 1994b Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. Journal of Experimental Medicine 180 995-1004.
294. Yang XD, Sytwu HK, McDevitt HO & Michie SA 1997 Involvement of β7 integrin and mucosal addressin cell adhesion molecule-1 (MADCAM-1) in the development of diabetes in obese diabetic mice. Diabetes 46 1542-1547.
295. Yasunami R & Bach JF 1988 Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD in mice. European Journal of Immunology 18 481-484.
296. Zaccoue P, Phillips J, Conget I, Gomis R, Haskins K, Minty A, Bendtzen K, Cooke A & Nicoletti F 1999 Interleukin-13 prevents autoimmune diabetes in NOD mice. Diabetes 48 1522-1528.
297. Zekzer D, Wong FS, Wen L, Altieri M, Gurlo T, von Grafenstein H & Sherwin RS 1997 Inhihition of diabetes by an insulin-reactive CD4 T-cell clone in the nonobese diabetic mouse. Diabetes 46 1124-1132.
298. Zheng XX, Steele AW, Hancock WW, Stevens AC, Nickerson PW, Roy-Chaudhury P, Tian Y & Strom TB 1997 A noncytolytic IL-10/fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice. Journal of Immunology 158 4507-4513.